Junshi Biosciences Announces Approval of the sNDA for Toripa

Junshi Biosciences Announces Approval of the sNDA for Toripalimab for the 1st-Line Treatment of Renal Cancer

Junshi Biosciences Announces Approval of the sNDA for Toripalimab for the 1st-Line Treatment of Renal Cancer

koreabizwire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from koreabizwire.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

Guangzhou , Guangdong , China , United States , San Francisco , California , Suzhou , Jiangsu , Australia , Shanghai , Maryland , Beijing , Singapore , Peking , Renji , Henan , Chinese , Zhi Li , Junshi Biosciences , Junshipharma Junshi Biosciences , Pabout Toripalimab , Shanghai Junshi Biosciences Co Ltd , Australia Therapeutic Goods Administration , Pr Team , European Medicines Agency , University Cancer Hospital , Singapore Health Sciences Authority , National Medical Products Administration , International Metastatic Renal Cell Carcinoma Database Consortium , National Reimbursement Drug List , Ir Team , Korea Bizwire , Professor Jun , Peking University Cancer Hospital , Professor Yiran , Renji Hospital Affiliated , Shanghai Jiao Tong University School , Independent Review Committee , Proffered Paper Session , European Society , Medical Oncology , Southeast Asia , Biologics License Application , Orphan Drug , For Global ,